PHAXIAM Therapeutics S.A. (PHXM) — Strategic Asset Allocation Index
PHAXIAM Therapeutics S.A. (PHXM) has a Strategic Asset Allocation Index of 22.8% as of June 2024. Strategic assets (PP&E of €3.52 Million plus long-term investments of €-) total €3.52 Million, measured against net assets of €15.45 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is PHAXIAM Therapeutics S.A.'s balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
PHAXIAM Therapeutics S.A. Strategic Asset Allocation Index (2010–2023)
This chart shows how PHAXIAM Therapeutics S.A.'s Strategic Asset Allocation Index has evolved across 12 annual periods from 2010 to 2023. As of June 2024, the index stands at 22.8%, representing strategic assets of €3.52 Million against net assets of €15.45 Million EUR. For live market cap and overall valuation, see market value of PHAXIAM Therapeutics S.A..
Annual Strategic Asset Allocation Index for PHAXIAM Therapeutics S.A. (2010–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for PHAXIAM Therapeutics S.A. from 2010 to 2023, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See PHXM net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 15.2% | €3.90 Million | €3.90 Million | €- | €25.61 Million | ▲ +2.5 pp |
| 2022 | 12.7% | €2.98 Million | €2.98 Million | €- | €23.49 Million | ▼ -100.4 pp |
| 2021 | 113.1% | €25.83 Million | €25.83 Million | €- | €22.84 Million | ▲ +3.4 pp |
| 2020 | 109.7% | €29.11 Million | €29.09 Million | €17.00K | €26.54 Million | ▲ +68.0 pp |
| 2019 | 41.7% | €35.66 Million | €35.64 Million | €17.00K | €85.56 Million | ▲ +31.1 pp |
| 2018 | 10.6% | €15.37 Million | €15.27 Million | €91.00K | €145.60 Million | ▲ +8.6 pp |
| 2017 | 1.9% | €3.47 Million | €3.41 Million | €66.00K | €181.42 Million | ▼ -4.4 pp |
| 2016 | 6.3% | €2.25 Million | €2.25 Million | €- | €35.64 Million | ▲ +4.4 pp |
| 2015 | 1.9% | €918.00K | €918.00K | €- | €47.13 Million | ▼ -0.8 pp |
| 2014 | 2.7% | €967.00K | €967.00K | €- | €35.82 Million | ▼ -3.3 pp |
| 2013 | 6.0% | €813.00K | €813.00K | €- | €13.59 Million | ▼ -24.1 pp |
| 2010 | 30.1% | €1.20 Million | €1.20 Million | €- | €3.99 Million | — |